14 Stocks Moving In Monday's After-Hours Session

Gainers

• HP HPQ shares are trading higher after the company reported better-than-expected Q1 EPS results. The company also issued FY20 EPS guidance above estimates and issued a $15 billion buyback.
• Keysight Technologies KEYS shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company issued Q2 sales guidance above estimates.
• Acer Therapeutics ACER shares are trading higher after the company reported ACER-001 trial shows bioequivalence to BUPHENYL.
• Intuit INTU shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
• Moderna MRNA shares are trading higher on a rumor that the company sent a coronavirus vaccine for human tests.
• Tenet Healthcare THC shares are trading higher after the company reported better-than-expected Q4 sales results. The company reported FY20 sales guidance above estimates.

Losers

• Kratos Defense & Security KTOS shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results. The company also issued Q1 sales guidance below estimates.
• Guardant Health GH shares are trading lower after the company reported Q4 earnings results.
• Hertz Global HTZ shares are trading lower after the company reported worse-than-expected Q4 sales results.
• Shake Shack SHAK shares are trading lower after the company reported worse-than-expected Q4 sales results. The company also issued FY20 sales guidance below estimates. The company reported Q4 comps down 3.6% year over year.
• Clovis Oncology CLVS shares are trading lower after the company reported worse-than-expected Q4 EPS results.
• Tandem Diabetes Care TNDM shares are trading lower after the company reported worse-than-expected Q4 sales results.
• EverQuote EVER shares are trading lower after the company reported Q4 earnings results.
• Palo Alto Networks PANW shares are trading lower after the company reported worse-than-expected Q2 sales results. The company issued Q3 and FY20 EPS and sales guidance below estimates.